Aardvark Therapeutics (AARD) Balance Sheet: Assets & Liabilities

Aardvark Therapeutics (AARD) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Aardvark Therapeutics reported total assets of $117.18M and total liabilities of $10.55M. Shareholders' equity was $106.63M. Total debt stood at $441.00K against $110.03M in cash and short-term investments, a net cash position of $109.59M. That puts debt-to-equity at 0.00.

Aardvark Therapeutics Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Aardvark Therapeutics, Inc. (AARD) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2024	FY 2023	FY 2022
Period ending	Dec 2025	Mar 2025	Dec 2024	Dec 2023	Dec 2022
Current Assets
Cash and Cash Equivalents	47.05	61.64	61.64	9.74	15.56
Short-Term Investments	62.98	12.02	12.02	0.25	0.55
Cash & Short-Term Investments	110.03	73.66	73.66	9.99	16.11
Accounts Receivable	0.00	0.00	-	0.00	0.00
Inventory	0.00	0.00	-	0.00	0.00
Other Current Assets	1.86	0.47	0.47	0.13	0.39
Total Current Assets	111.89	74.14	74.14	10.37	16.49
Non-Current Assets
Property, Plant & Equipment (Net)	0.36	0.74	0.74	0.16	0.25
Other Non-Current Assets	4.94	2.64	2.64	0.01	0.01
Total Non-Current Assets	5.30	3.37	3.37	0.17	0.27
Total Assets	117.18	77.51	77.51	10.54	16.76
Current Liabilities
Accounts Payable	2.07	2.30	2.30	1.04	0.26
Short-Term Debt	0.44	0.34	-	0.11	0.10
Accrued Liabilities	8.04	-	1.40	0.19	0.24
Other Current Liabilities	8.04	2.29	-	0.24	0.24
Total Current Liabilities	10.55	4.93	4.93	1.38	0.60
Non-Current Liabilities
Long-Term Debt	0.00	0.44	0.44	0.05	0.16
Other Non-Current Liabilities	0.00	126.78	0.03	0.00	0.02
Total Non-Current Liabilities	0.00	127.22	127.22	43.96	0.18
Total Liabilities	10.55	132.15	132.15	45.34	0.78
Stockholders' Equity
Retained Earnings	-115.92	-58.33	-58.33	-37.74	-30.53
Accumulated Other Comprehensive Income	0.08	0.00	-	0.00	0.00
Additional Paid-in Capital	222.47	3.68	3.68	2.94	2.61
Shares Outstanding	21.82	-	21.69	21.38	21.38
Total Stockholders' Equity	106.63	-54.64	-54.64	-34.80	15.98
Total Liabilities & Equity	117.18	77.51	77.51	10.54	16.76

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Aardvark Therapeutics Balance Sheet

How much debt does Aardvark Therapeutics have?

Aardvark Therapeutics had total debt of $441.00K as of Dec 31, 2025, against $110.03M in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was $779.00K a year earlier.

What are Aardvark Therapeutics's total assets?

Aardvark Therapeutics reported total assets of $117.18M as of Dec 31, 2025, up 51.2% from $77.51M a year earlier. Total liabilities were $10.55M.

What is Aardvark Therapeutics's shareholders' equity?

Aardvark Therapeutics's shareholders' equity was $106.63M as of Dec 31, 2025, or about $4.89 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition